Quest Diagnostics raises 2026 guidance on utilization and margin outlook
Quest Diagnostics said it raised its 2026 guidance, citing robust utilization, expected margin expansion as integration costs subside, and growth momentum in its consumer business.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.